oversold

12 articles
Investing.comInvesting.com··Nathan Reiff

D-Wave's 44% Plunge Masks Quantum Leap: Growth Story vs. Valuation Reality

D-Wave ($QBTS) fell 44% in 2026 despite strong bookings exceeding 2025 totals and $30M in major deals. Analysts see 132% upside, but 237x sales valuation remains extreme.
QBTSstock declinevaluation
The Motley FoolThe Motley Fool··Justin Pope

Broadcom's AI Chip Boom Offers 51% Upside as Stock Hits Oversold Territory

Broadcom stock down 25% from highs amid selling pressure, but AI ASIC business poised for explosive growth with analysts projecting 51% median upside.
NVDAMETAGOOGGOOGLAVGOAI chipsvaluation
The Motley FoolThe Motley Fool··Jeremy Bowman

Lululemon's 68% Plunge: Oversold Bargain or Value Trap?

$LULU plummeted 68% from 2023 highs amid slowing growth and competition, now trading at 14x forward earnings. International expansion and new products offer turnaround potential.
LULUvaluationmargin compression
The Motley FoolThe Motley Fool··Will Healy

Oracle and Sea Limited Show Signs of Oversold Recovery as Fundamentals Strengthen

Oracle and Sea Limited appear oversold after 50%+ declines despite strong fundamentals: Oracle's $553B backlog and 84% cloud growth; Sea's 36% revenue expansion across fintech and gaming.
AMZNMELIORCLORCLpDSEvaluationAI infrastructure
BenzingaBenzinga··Lekha Gupta

Meiwu Technology Plummets 39% on Direct Offering, AI Push Fails to Stem Selloff

Meiwu Technology shares fell 39.47% Wednesday after announcing a $14 million direct offering of 7 million shares and a strategic AI skincare initiative.
WNWtechnical analysisregistered direct offering
Investing.comInvesting.com··Sam Quirke

Wells Fargo, Goldman Sachs Hit Oversold Territory Amid Sector Turmoil

Wells Fargo and Goldman Sachs tumbled ~20% from highs despite strong 2025 gains. Both stocks show oversold signals with analysts seeing buying opportunities ahead of earnings.
GSGSpAGSpCGSpDWFC+6financial stockstechnical analysis
BenzingaBenzinga··Vandana Singh

Tevogen Bio Pursues Apozeal Acquisition to Strengthen Generics Portfolio

Tevogen Bio ($TVGN) pursues Apozeal acquisition to bolster generics platform; stock plunges 15.41% despite initial rally, trading at 52-week lows amid strategic uncertainty.
TVGNTVGNWacquisitionreverse stock split
BenzingaBenzinga··Erica Kollmann

China Tech and Emerging Markets Hit Oversold Levels, Signaling Potential Rebound

China tech stocks and emerging market ETFs hit oversold extremes with depressed RSI readings, signaling potential rebound if risk sentiment improves.
BABANVOJDSEKWEB+4emerging marketse-commerce
Investing.comInvesting.com··Sam Quirke

PayPal Trades at IPO Valuations Amid Growth Headwinds and Market Competition

PayPal shares hit IPO-era lows amid slowing growth and Apple/Stripe competition, though some see 35% upside potential if the company can reignite revenue expansion.
AAPLPYPLvaluationCEO transition
BenzingaBenzinga··Lekha Gupta

Similarweb Faces Analyst Downgrades on Missed Guidance and Revenue Shortfall

Similarweb missed Q4 revenue targets and issued conservative 2026 guidance, triggering analyst downgrades over sales execution concerns and AI sector uncertainty.
SMWBearnings missAI disruption
BenzingaBenzinga··Lekha Gupta

Upwork Authorizes $300M Buyback as Platform Returns to Growth

Upwork shares jumped 6.90% after board approval of a $300M buyback program, signaling confidence as the freelance platform returns to growth and reports record 2025 performance.
UPWKIBUYAI investmentshareholder value
Investing.comInvesting.com··Sam Quirke

Amazon Stock Enters Oversold Territory as Technical Indicators Mirror Prior Rally Signals

Amazon stock fell 20% from November peak, entering oversold territory with RSI below 30—historically signaling recovery. Analysts remain bullish with $300+ price targets.
AMZNearnings misscapital expenditure